- Title
- Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4- dimethyl-benziso-(2H)- selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase
- Creators
- David J GREENBLATT - Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, United StatesDiane E PETERS - Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, United StatesLauren E OLESON - Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, United StatesJerold S HARMATZ - Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, United StatesMalcolm W MACNAB - Synvista Therapeutics, Inc, Montvale, NJ, United StatesNoah BERKOWITZ - Synvista Therapeutics, Inc, Montvale, NJ, United StatesMiguel A ZINNY - ProMedica Clinical Research Center, Boston MA, United StatesMichael H COURT - Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, United States
- Publication Details
- British journal of clinical pharmacology, Vol.68(6), pp.920-927
- Academic Unit
- Veterinary Clinical Sciences, Department of
- Publisher
- Blackwell; Oxford
- Identifiers
- 99900546607801842
- Language
- English
- Resource Type
- Journal article
Journal article
Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4- dimethyl-benziso-(2H)- selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase
British journal of clinical pharmacology, Vol.68(6), pp.920-927
2009
Handle:
https://hdl.handle.net/2376/106351
PMCID: PMC2810804
PMID: 20002087
Abstract
Metrics
8 Record Views